SEGMENT INFORMATION - Schedule of Information About Reported Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
REVENUE AND DEFERRED REVENUE
Revenue	$ 31,975	$ 17,417
Cost of revenues	16,237	4,329
Segment Gross profit	15,738	13,088
Research and development	1,616	2,349
Loss from operations	(11,014)	(6,859)
Interest expense	1,922	1,826
Other income, net	(247)	(812)
Net loss	(12,689)	(7,873)
Medical Device
REVENUE AND DEFERRED REVENUE
Revenue	31,975	17,417
Cost of revenues	16,237	4,329
Segment Gross profit	15,738	13,088
Personnel	17,676	12,138
Marketing	2,937	2,228
Research and development	255	800
Professional fees	1,445	1,103
Other segment expenses	$ 4,440	$ 3,678
Segment Reporting Other Item Composition Description	Other segment expenses include travel and entertainment, bad debt, depreciation and amortization, insurance, rent, and other costs.	Other segment expenses include travel and entertainment, bad debt, depreciation and amortization, insurance, rent, and other costs.
Loss from operations	$ (11,014)	$ (6,859)
Interest expense	1,922	1,826
Other income, net	(247)	(812)
Net loss	$ (12,689)	$ (7,873)